Dexcom $75M Bet on Oura

Diving deeper into

Oura

Company Report
Dexcom, which also made a separate $75M strategic investment to support the companies' glucose monitoring integration.
Analyzed 9 sources

Dexcom’s $75M check shows this was not a simple app integration, it was a distribution and product bet that helped pull Oura into metabolic health. Dexcom brought the glucose sensor, Oura brought the ring, habit data, and consumer engagement layer. Together they created a workflow where a member can see how a meal changes glucose, then connect that spike to sleep, stress, activity, and recovery inside one app.1 2 3 4 5

  • The partnership was announced on November 19, 2024, alongside Oura’s Series D. Dexcom said the deal included a two way data flow between Dexcom biosensors and Oura’s app and ring, plus co marketing, which makes the investment look like a go to market partnership, not passive venture exposure.1 2
  • Oura turned that partnership into a shipped product in May 2025 with Glucose and Meals. In practice, Stelo readings flow into the Oura app, where members can log meals and see glucose curves next to sleep, stress, and activity data. That extends Oura from a sleep and recovery ring into a broader daily health coach.3 4 5 6
  • The competitive angle is important. Ultrahuman had already linked rings and glucose, but it depended on third party sensors. By aligning with Dexcom, Oura gained a frontline CGM partner and made its app a stronger home for sensor data, while Dexcom gained access to Oura’s large wellness audience outside traditional diabetes care.7 8 9

Going forward, the ring is becoming the always on engagement layer, while glucose sensing becomes one of several paid add ons around it. That points to Oura selling a wider health bundle with hardware, membership, labs, and sensors, and to Dexcom using software partnerships to push CGM beyond diabetes into mainstream preventive health.3 5 6 9